生命科学资讯

FDA accepts filing for Moderna flu vaccine after swift rethink

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal

Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug

Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal

Thermo Fisher Launches Kit for Sequential Protein, DNA and RNA Extraction - Contract Pharma

Novartis signs macrocyclic deal with Unnatural Products for $100M upfront

Reversal on Moderna's flu application follows atypical path through FDA

FDA accepts BMS protein degrader for review; Disc rare disease drug rejected

Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results

Faeth goes public in merger with Sensei, nets $200M in stock sale

Pharma could be on the cusp of finally breaking the blood-brain barrier

AI is slashing jobs across industries. Will pharma be next?

FDA reverses course, will review Moderna’s flu vaccine

CRB recruits construction leader after wave of leadership changes - The Business Journals

Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life

Danaher buys patient monitoring specialist Masimo in $9.9B deal

Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study

Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody

Lilly licenses CSL’s IL-6 immuno-inflammatory antibody for $100M upfront

Paragon's new biotech Korsana tackles Alzheimer's like Roche